A citation-based method for searching scientific literature

Ruben P A van Eijk, Tessa Kliest, Christopher J McDermott, Kit C B Roes, Philip Van Damme, Adriano Chio, Markus Weber, Caroline Ingre, Philippe Corcia, Mònica Povedano, Evy Reviers, Michael A van Es, Ammar Al-Chalabi, Orla Hardiman, Leonard H van den Berg. Amyotroph Lateral Scler Frontotemporal Degener 2020
Times Cited: 9







List of co-cited articles
17 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Power calculations for clinical trials in Alzheimer's disease.
M Colin Ard, Steven D Edland. J Alzheimers Dis 2011
47
33

Refining eligibility criteria for amyotrophic lateral sclerosis clinical trials.
Ruben P A van Eijk, Henk-Jan Westeneng, Stavros Nikolakopoulos, Iris E Verhagen, Michael A van Es, Marinus J C Eijkemans, Leonard H van den Berg. Neurology 2019
36
33

Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model.
Henk-Jan Westeneng, Thomas P A Debray, Anne E Visser, Ruben P A van Eijk, James P K Rooney, Andrea Calvo, Sarah Martin, Christopher J McDermott, Alexander G Thompson, Susana Pinto,[...]. Lancet Neurol 2018
157
33

ALS clinical trials: do enrolled patients accurately represent the ALS population?
A Chiò, A Canosa, S Gallo, S Cammarosano, C Moglia, G Fuda, A Calvo, G Mora. Neurology 2011
67
33

A proposal for new diagnostic criteria for ALS.
Jeremy M Shefner, Ammar Al-Chalabi, Mark R Baker, Li-Ying Cui, Mamede de Carvalho, Andrew Eisen, Julian Grosskreutz, Orla Hardiman, Robert Henderson, Jose Manuel Matamala,[...]. Clin Neurophysiol 2020
65
22

Stage at which riluzole treatment prolongs survival in patients with amyotrophic lateral sclerosis: a retrospective analysis of data from a dose-ranging study.
Ton Fang, Ahmad Al Khleifat, Jacques-Henri Meurgey, Ashley Jones, P Nigel Leigh, Gilbert Bensimon, Ammar Al-Chalabi. Lancet Neurol 2018
85
22


El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis.
B R Brooks, R G Miller, M Swash, T L Munsat. Amyotroph Lateral Scler Other Motor Neuron Disord 2000
22

Biochemical characterization of plasma in amyotrophic lateral sclerosis: amino acid and protein composition.
Angelina Palma, Mamede de Carvalho, Nuno Barata, Teresinha Evangelista, Paula Chicau, Manuela Regalla, Júlia Costa. Amyotroph Lateral Scler Other Motor Neuron Disord 2005
13
22

Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trial.
Merit E Cudkowicz, Leonard H van den Berg, Jeremy M Shefner, Hiroshi Mitsumoto, Jesus S Mora, Albert Ludolph, Orla Hardiman, Michael E Bozik, Evan W Ingersoll, Donald Archibald,[...]. Lancet Neurol 2013
150
22

Revised Airlie House consensus guidelines for design and implementation of ALS clinical trials.
Leonard H van den Berg, Eric Sorenson, Gary Gronseth, Eric A Macklin, Jinsy Andrews, Robert H Baloh, Michael Benatar, James D Berry, Adriano Chio, Philippe Corcia,[...]. Neurology 2019
62
22

Critical design considerations for time-to-event endpoints in amyotrophic lateral sclerosis clinical trials.
Ruben P A van Eijk, Stavros Nikolakopoulos, Kit C B Roes, Bas M Middelkoop, Toby A Ferguson, Pamela J Shaw, P Nigel Leigh, Ammar Al-Chalabi, Marinus J C Eijkemans, Leonard H van den Berg. J Neurol Neurosurg Psychiatry 2019
6
33

Analysis of start-up, retention, and adherence in ALS clinical trials.
Nazem Atassi, Padmaja Yerramilli-Rao, Jackie Szymonifka, Hong Yu, Marianne Kearney, Daniela Grasso, Jing Deng, Mark Levine-Weinberg, Jordan Shapiro, Alexandra Lee,[...]. Neurology 2013
22
22

Development and assessment of the inter-rater and intra-rater reproducibility of a self-administration version of the ALSFRS-R.
Leonhard A Bakker, Carin D Schröder, Harold H G Tan, Simone M A G Vugts, Ruben P A van Eijk, Michael A van Es, Johanna M A Visser-Meily, Leonard H van den Berg. J Neurol Neurosurg Psychiatry 2020
14
22

Accelerometry for remote monitoring of physical activity in amyotrophic lateral sclerosis: a longitudinal cohort study.
Ruben P A van Eijk, Jaap N E Bakers, Tommy M Bunte, Arianne J de Fockert, Marinus J C Eijkemans, Leonard H van den Berg. J Neurol 2019
11
22

ALS longitudinal studies with frequent data collection at home: study design and baseline data.
Seward B Rutkove, Kristin Qi, Kerisa Shelton, Julie Liss, Visar Berisha, Jeremy M Shefner. Amyotroph Lateral Scler Frontotemporal Degener 2019
22
22

Monitoring disease progression with plasma creatinine in amyotrophic lateral sclerosis clinical trials.
Ruben P A van Eijk, Marinus J C Eijkemans, Toby A Ferguson, Stavros Nikolakopoulos, Jan H Veldink, Leonard H van den Berg. J Neurol Neurosurg Psychiatry 2018
40
22

Mislocalisation of TDP-43 to the cytoplasm causes cortical hyperexcitability and reduced excitatory neurotransmission in the motor cortex.
Marcus S Dyer, Laura A Reale, Katherine E Lewis, Adam K Walker, Tracey C Dickson, Adele Woodhouse, Catherine A Blizzard. J Neurochem 2021
6
16

Cortical hyperexcitability evolves with disease progression in ALS.
Parvathi Menon, Mana Higashihara, Mehdi van den Bos, Nimeshan Geevasinga, Matthew C Kiernan, Steve Vucic. Ann Clin Transl Neurol 2020
15
11

Use of Multimodal Imaging and Clinical Biomarkers in Presymptomatic Carriers of C9orf72 Repeat Expansion.
Joke De Vocht, Jeroen Blommaert, Martijn Devrome, Ahmed Radwan, Donatienne Van Weehaeghe, Maxim De Schaepdryver, Jenny Ceccarini, Ahmadreza Rezaei, Georg Schramm, June van Aalst,[...]. JAMA Neurol 2020
15
11

Connectome-Based Propagation Model in Amyotrophic Lateral Sclerosis.
Jil M Meier, Hannelore K van der Burgh, Abram D Nitert, Peter Bede, Siemon C de Lange, Orla Hardiman, Leonard H van den Berg, Martijn P van den Heuvel. Ann Neurol 2020
15
11

Is it accurate to classify ALS as a neuromuscular disorder?
Michael A van Es, H Stephan Goedee, Henk-Jan Westeneng, Tanja C W Nijboer, Leonard H van den Berg. Expert Rev Neurother 2020
5
20

Patterned functional network disruption in amyotrophic lateral sclerosis.
Stefan Dukic, Roisin McMackin, Teresa Buxo, Antonio Fasano, Rangariroyashe Chipika, Marta Pinto-Grau, Emmet Costello, Christina Schuster, Michaela Hammond, Mark Heverin,[...]. Hum Brain Mapp 2019
31
11

Trial of Sodium Phenylbutyrate-Taurursodiol for Amyotrophic Lateral Sclerosis.
Sabrina Paganoni, Eric A Macklin, Suzanne Hendrix, James D Berry, Michael A Elliott, Samuel Maiser, Chafic Karam, James B Caress, Margaret A Owegi, Adam Quick,[...]. N Engl J Med 2020
44
11

Phase 1-2 Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS.
Timothy Miller, Merit Cudkowicz, Pamela J Shaw, Peter M Andersen, Nazem Atassi, Robert C Bucelli, Angela Genge, Jonathan Glass, Shafeeq Ladha, Albert L Ludolph,[...]. N Engl J Med 2020
90
11


ROCK-ALS: Protocol for a Randomized, Placebo-Controlled, Double-Blind Phase IIa Trial of Safety, Tolerability and Efficacy of the Rho Kinase (ROCK) Inhibitor Fasudil in Amyotrophic Lateral Sclerosis.
Paul Lingor, Markus Weber, William Camu, Tim Friede, Reinhard Hilgers, Andreas Leha, Christoph Neuwirth, René Günther, Michael Benatar, Magdalena Kuzma-Kozakiewicz,[...]. Front Neurol 2019
28
11

Main changes in European Clinical Trials Regulation (No 536/2014).
E Tenti, G Simonetti, M T Bochicchio, G Martinelli. Contemp Clin Trials Commun 2018
14
11

Ultra-high-dose methylcobalamin in amyotrophic lateral sclerosis: a long-term phase II/III randomised controlled study.
Ryuji Kaji, Takashi Imai, Yasuo Iwasaki, Koichi Okamoto, Masanori Nakagawa, Yasuo Ohashi, Takao Takase, Takahisa Hanada, Hiroki Shimizu, Kunio Tashiro,[...]. J Neurol Neurosurg Psychiatry 2019
22
11

Rare disease registries: potential applications towards impact on development of new drug treatments.
Marijke C Jansen-van der Weide, Charlotte M W Gaasterland, Kit C B Roes, Caridad Pontes, Roser Vives, Arantxa Sancho, Stavros Nikolakopoulos, Eric Vermeulen, Johanna H van der Lee. Orphanet J Rare Dis 2018
18
11


Bipap improves survival and rate of pulmonary function decline in patients with ALS.
K A Kleopa, M Sherman, B Neal, G J Romano, T Heiman-Patterson. J Neurol Sci 1999
256
11

Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial.
Stephen C Bourke, Mark Tomlinson, Tim L Williams, Robert E Bullock, Pamela J Shaw, G John Gibson. Lancet Neurol 2006
556
11

Objective measures of the efficacy of noninvasive positive-pressure ventilation in amyotrophic lateral sclerosis.
L S Aboussouan, S U Khan, M Banerjee, A C Arroliga, H Mitsumoto. Muscle Nerve 2001
99
11

Intermittent hypoxia can aggravate motor neuronal loss and cognitive dysfunction in ALS mice.
Sung-Min Kim, Heejaung Kim, Jeong-Seon Lee, Kyung Seok Park, Gye Sun Jeon, Jeeheun Shon, Suk-Won Ahn, Seung Hyun Kim, Kyung Min Lee, Jung-Joon Sung,[...]. PLoS One 2013
30
11

EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)--revised report of an EFNS task force.
Peter M Andersen, Sharon Abrahams, Gian D Borasio, Mamede de Carvalho, Adriano Chio, Philip Van Damme, Orla Hardiman, Katja Kollewe, Karen E Morrison, Susanne Petri,[...]. Eur J Neurol 2012
553
11

NIV in amyotrophic lateral sclerosis: The 'when' and 'how' of the matter.
Capucine Morelot-Panzini, Gaëlle Bruneteau, Jesus Gonzalez-Bermejo. Respirology 2019
16
11


Randomised controlled trial of polysomnographic titration of noninvasive ventilation.
Liam M Hannan, Linda Rautela, David J Berlowitz, Christine F McDonald, Jennifer M Cori, Nicole Sheers, Caroline Chao, Fergal J O'Donoghue, Mark E Howard. Eur Respir J 2019
16
11

Oxidative stress in ALS: a mechanism of neurodegeneration and a therapeutic target.
Siân C Barber, Richard J Mead, Pamela J Shaw. Biochim Biophys Acta 2006
288
11

Identifying who will benefit from non-invasive ventilation in amyotrophic lateral sclerosis/motor neurone disease in a clinical cohort.
David J Berlowitz, Mark E Howard, Julio F Fiore, Stephen Vander Hoorn, Fergal J O'Donoghue, Justine Westlake, Anna Smith, Fiona Beer, Susan Mathers, Paul Talman. J Neurol Neurosurg Psychiatry 2016
61
11



Noninvasive positive-pressure ventilation in ALS: predictors of tolerance and survival.
D Lo Coco, S Marchese, M C Pesco, V La Bella, F Piccoli, A Lo Coco. Neurology 2006
79
11

Noninvasive Ventilation Use Is Associated with Better Survival in Amyotrophic Lateral Sclerosis.
Jason Ackrivo, Jesse Y Hsu, John Hansen-Flaschen, Lauren Elman, Steven M Kawut. Ann Am Thorac Soc 2021
5
20

CX3CR1 is a modifying gene of survival and progression in amyotrophic lateral sclerosis.
Alan Lopez-Lopez, Josep Gamez, Emilio Syriani, Miguel Morales, Maria Salvado, Manuel J Rodríguez, Nicole Mahy, Jose M Vidal-Taboada. PLoS One 2014
36
11

Regulation of microtubule dynamics by the neuronal growth-associated protein SCG10.
B M Riederer, V Pellier, B Antonsson, G Di Paolo, S A Stimpson, R Lütjens, S Catsicas, G Grenningloh. Proc Natl Acad Sci U S A 1997
160
11

Transcriptional regulation of PRPF31 gene expression by MSR1 repeat elements causes incomplete penetrance in retinitis pigmentosa.
Anna M Rose, Amna Z Shah, Giulia Venturini, Abhay Krishna, Aravinda Chakravarti, Carlo Rivolta, Shomi S Bhattacharya. Sci Rep 2016
30
11

Isolation of adult stem cells from the human olfactory mucosa.
François Féron, Chris Perry, Stéphane D Girard, Alan Mackay-Sim. Methods Mol Biol 2013
39
11



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.